Study identifier:NIS-RRS-XXX-2011/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Observational study to evaluate the correctness of the use of inhaler device in patients with asthma or chronic obstruct
Asthma,
-
No
-
All
310
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Mar 2014 by AstraZeneca
AstraZeneca
-
The correct use of inhalation devices is an inclusion criterion for all studies comparing inhaled treatments. In real life, however, patients may make many errors with their usual inhalation device, which may negate the benefits observed in clinical trials. In real life, many errors seem to be made, but no wide-scale evaluation has been performed. The correct use of inhalation devices is essential to ensure the effectiveness of the treatment. It has been recently demonstrated that inhaler misuse is associated with decreased asthma control in asthmatics treated with an inhaled corticosteroid. The aim of our observational study was to evaluate the inhaler device usage in patients with asthma or chronic obstructive pulmonary disease (COPD).
Observational study to evaluate the correctness of the use of inhaler device in patients with asthma or chronic obstruct
Location
Location
Belgrade, Serbia
Location
Sremska Kamenica, Serbia
Location
Kragujevac, Serbia
Location
Nis, Serbia
Location
Sombor, Serbia
Arms | Assigned Interventions |
---|---|
1 The inhaler device usage in patients with asthma or COPD | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.